Latest on ADHD
New medication, Intuniv XR
Health Canada has recently approved a new medication, Intuniv XR (guanfacine hydrochloride extended-release tablets) , for the treatment of ADHD in children aged 6 to 12 years as monotherapy and as adjunctive therapy to psychostimulants in cases when psychostimulants are associated with a sub-optimal response. Guanfacine is a selective alpha-2a-adrenergic receptor agonist. Extended-released guanfacine is available since a few years in the United States and should be available in phamacies in Canada before the end of 2013. CADDRA website will soon offer more informations for clinicians (check for the CADDRA guidelines updates).
DSM-5 is now available: what's new for ADHD?
Did you know? For the first time, Canada had its ADHD Awereness Week Week (same week as in the United States: October 15-21 2012).
Now available online in many languages!
DIVA 2.0 is a structured Diagnostic Interview for Adult ADHD, second edition, developped par Dr Sandra Kooij and her team. http://www.divacenter.eu/DIVA.aspx?id=461
You can get the DIVA 2.0 App, both at Google Play and Apple Store!
New Ontario Ministry of Education Memorandum
A new Ministry memorandum to school boards states that students with ADHD who have learning-based needs should be identified as exceptional students, and can be recognized under a variety of categories. The memorandum goes several steps further and states that children can be categorized in the Communication (learning disability) category regardless of whether criteria for a learning disability are met. The memorandum outlines areas in which students with ADHD may demonstrate learning needs, but clarifies that needs are not limited to this list. CADDAC congratulates the Ministry for this first step in correcting a long-standing inequity of access to special education services for students with ADHD and other neurobiological disorders.
To view the Ontario Ministry of Education Memorandum
To view the CADDAC January 10th, 2012 press release
To view theToronto STAR article